Talk by Anthony Don, University of New South Wales, Sydney

Developing ceramide synthase inhibitors for insulin resistance and neurodegenerative disease

  • Date: Jun 13, 2016
  • Time: 14:00 - 15:00
  • Speaker: Dr. Anthony Don
  • Research Group Leader, Metabolite Signalling, Senior Lecturer, Prince of Wales Clinical School, Faculty of Medicine University of New South Wales, Sydney, Australia
  • Location: MPI for Metabolism Research, Gleueler Strasse 50, 50931 Köln
  • Room: Seminar room 1
  • Host: Dr. Sarah Turpin-Nolan
  • Contact: Sarah.Turpin-Nolan@sf.mpg.de
Talk by Anthony Don, University of New South Wales, Sydney
Go to Editor View